Albert Lowe

Stock Analyst at Craig-Hallum

(1.57)
# 3,466
Out of 5,090 analysts
10
Total ratings
22.22%
Success rate
5.52%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Albert Lowe

Palvella Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $175
Current: $100.40
Upside: +74.30%
Neurogene
Jun 17, 2025
Initiates: Buy
Price Target: $50
Current: $20.38
Upside: +145.34%
Atossa Therapeutics
Jun 5, 2025
Initiates: Buy
Price Target: $4
Current: $0.80
Upside: +400.47%
Opus Genetics
Apr 11, 2025
Initiates: Buy
Price Target: $6
Current: $2.28
Upside: +163.74%
Skye Bioscience
Mar 21, 2025
Maintains: Buy
Price Target: $18$14
Current: $1.22
Upside: +1,047.54%
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $3.98
Upside: +176.38%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $2.11
Upside: +280.05%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $1.72
Upside: +132.56%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%